The abstract is read at the publisher; the summary is JClub's.
cGAS-STING signaling is a central regulator of immune surveillance in pulmonary, gastrointestinal, and cutaneous epithelia, but dysregulated activation can drive unresolved inflammation and tissue damage.
- Why it matters: The field needs ways to modulate this pathway for therapeutic benefit without losing its protective roles, despite context-dependent effects.
- What they did: This review synthesizes evidence on cGAS-STING in epithelia and maps key inflammatory nodes to therapeutic strategies in preclinical and clinical development, including small-molecule antagonists, pathway modulators, and PROTAC-based degraders.
- The result: The work highlights how tissue-directed delivery and translational challenges may shape clinical application of cGAS-STING-targeted therapies.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.